Pharmaceutical company Eli Lilly explained the lack of diabetes drug “Trulicity” in the Russian Federation with a surge in demand

Unprecedented demand for the diabetes drug Trulicity was recorded in Russia, which led to a shortage of the drug in Russian pharmacies. However, state orders continue to be provided, drugs are supplied from abroad to the Russian Federation, the pharmaceutical company Eli Lilly Pharma said.

“Today, Lilly continues to supply Trulicity to Russian distributors in Russia and is making every effort to continue uninterrupted supplies in the future and maintain its availability on the market for patients,” the press service of Eli Lilly Pharma said. “RIA Novosti”.

According to a company representative, unprecedented demand for Trulicity has been recorded not only in Russia, but also in other countries.

In order to prevent shortages of the drug, the Russian branch imports the drug in a package intended for circulation in the territory of a foreign state. Thanks to this, during the eleven months of 2022, the company sold a volume that exceeded sales in the same period last year by 8%.

“It is important to note that today Lilly continues to supply drugs included in the list of vital and essential drugs for patients in Russia who need the treatment of diabetes, oncological, autoimmune and neurological diseases,” noted Eli Lilly Pharma.

The fact that Trulicity almost completely disappeared from Moscow pharmacies was previously reported Vedomosti. In pharmacies where the drug remained in stock, its cost is three times higher than the maximum selling price. Patients have to search for a medicine in thematic groups on social networks, despite the fact that it is prescribed by prescription. “Trulicity” is included in the list of vital drugs, it has no analogues in terms of the active substance.

Daria Erozbek